Together, these results provided no evidence of association with strong increased risk (OR≥1.3, based on our power calculations; S4–S6 Figs) between the RA-protecting TYK2 variants and any of the PheWAS phenotypes tested. Here, TYK2 is linked to rheumatoid arthritis.